The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
News on the Alzheimer's Disease test is also due anytime now !
This will be a game changer once it is fine tuned and marketed worldwide !
Skip
Bath university. No mention of anyone else
Good to see any progress from anywhere to help with Alzheimer’s TBH
Who's they? Bath Uni or Paraytec?
Just watching bbc west reporting on Bath University, they think they’re on to something
This is one of only a few days that you will be able to get in this Fantastic Share if not already at this amazingly low price of 41p !
The potential here is HUGE !
This just don't want to break 42... come buyers.... let's break that and get over 45
Yeah 42p has and stil is the current Resistance Level so if we can get past 42p we are into clear space !
Can buy still at 41.75 but few buys and 42 will be gone for good hopefully
SP HAS JUST HIT 42p UP SHE GOES !!!
Castley
Nice One !
We have had another good day today SP up to and closed at 41.00p up +2.50 +6.45%
A nice leg up and ready to build up from tomorrow !
Good Luck All
StarKnight
Volume is 3.8 mill. Wow!!
Volume now over 3.5 million and rising !!
NT to buy !!!
She is gonna blow !!
Good Luck All
StarKnight
Yes still underwater , but surviving, on optimism,
ALL THE WAY NT TO BUY... SEEMS LIKE PEOPLE ARE PLACING ORDERS AS WHEN ASK RISES... GONE STRAIGHT AWAY
Hopefully over £1.20 :) I will be level again
Hopefully back to over £1/share
37 gone now... any one waiting best to pick up every time little drop happens... 40 plus today
Another 20-30% rise on the cards
Paralytec sale for 80 mill sounds good to me
Top up 40,785k at 36 should show shortly upwards and onwards GLA easy money lol
This going to start to motor TB Knows and his cronies
....... up..... we ....... Go
Looking forward to the news
TB is on a mission , no excuses to pull this off he's determined....
University open and testing complete ..
The Herd will arrive...
Topping up is the right way to bring your average down ,, from the highs of £1.20 top ups to the lows my average is nicely set hope yours is too.
Let's hope the SP moves forward quickly so most can get into a profit..
Luck for the investors who are already..
Castle .
Paddyboy
b ottom paragraph from page 1 of my post !
Prototype instruments were shipped to project partners in early July 2021 and sample testing has commenced. The initial results from Vrije University Medical Centre Amsterdam (VUMC) using AD patient samples were inconclusive. The cause and implications of these initial results are not yet known. Further testing is needed and although the funded project will end at the end of this month, Paraytec's partners have indicated that they will continue the testing thereafter. A further update is expected by the end of September 2021.
The reason that the results on the Alzheimer’s Test are inconclusive is because the Universities and other relevant parties have been on summer holiday so this, I believe has caused a delay. The Universities return function in September and so that is the reason the results will not be published until the end of September.
The RNS on the 4th August was not quite clear why the results are inconclusive so this is the actual reason and not that there is a device failure as far as I know
Good Luck All
StarKnight
Paddyboy
20% rise today was not on nothing ! Read my posts ! I have researched and the results of the Alzheimers's Disease test which in the last information RNS were inconclusive,well the results were inconclusive because the University and assocuated partners were on holiday all at differnt times in August and that is why the results were inconclusive because there were delays to to staff holidays !
We should go way past 40p tomorrow
Good Luck All
StarKnight
18p just a couple of weeks ago. What a bunch this lot are.
Placing to raise £2.5 million
Braveheart Investment Group (AIM: BRH), is pleased to announce a placing of 13,888,889 new ordinary shares of 2 pence each in the Company ("Placing Shares") at a price of 18 pence per share ("Placing Price"), raising gross proceeds of £2,500,000 before expenses (the "Placing").
Highlights
· Fundraise of £2,500,000, through a placing by the Company's broker, Peterhouse Capital Limited of 13,888,889 new ordinary shares of 2 pence each in the Company at an issue price of 18 pence per Placing Share.
· The Placing Shares will represent approximately 26.59 per cent. of the enlarged issued share capital of the Company.
· The Placing Shares are being issued at a price of 18 pence per Placing Share, representing a discount of approximately 20.88 per cent. to the closing mid-market share price of an existing ordinary share on 12 August 2021, the business day prior to this announcement.
· The Company has utilised its existing authority to issue new ordinary shares for cash on a non-pre-emptive basis.
· Trevor Brown, Chief Executive of the Company has subscribed for 3,500,000 Placing Shares and Free Association Books Limited, a company which is connected to Trevor Brown, has subscribed for 4,500,000 Placing Shares.
· Vivian Hallam, Executive Director of the Company, has subscribed for 833,333 shares in the Placing.
Trevor Brown, Braveheart CEO, commented: "We are delighted to have been able to raise this extra funding which will enable Paraytec to pursue its new strategy."